Copyright
©The Author(s) 2016.
World J Hepatol. Aug 8, 2016; 8(22): 949-956
Published online Aug 8, 2016. doi: 10.4254/wjh.v8.i22.949
Published online Aug 8, 2016. doi: 10.4254/wjh.v8.i22.949
Table 3 Adverse events (%) and treatment discontinuation
| Adverse events (73.9%) | |
| Anemia | 52.9 |
| Asthenia | 39.6 |
| Neutro/thrombopenia | 29.6 |
| Dysgeusia | 8.6 |
| Psychiatric disorders | 6.7 |
| Anorectal symptoms | 5.9 |
| Others (see text) | 14.9 |
| Treatment discontinuation (122 cases; 14.6%) | Number of cases |
| Rash/Itch | 36 (29.5%) |
| Anemia | 28 (22.9%) |
| Asthenia | 18 (14.7%) |
| Psychiatric disorders | 6 (5%) |
| Pancytopenia | 3 (2.5%) |
| Neutro/thrombopenia | 3 (2.5%) |
| Others (see text) | 28 (22.9%) |
- Citation: CLEO Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D’Adamo G, D’Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Giacomo A, De Marco R, De Stefano G, De Stefano G, Di Salvo S, Di Sarno R, Farella N, Felicioni L, Fimiani B, Fontanella L, Foti G, Furlan C, Giancotti F, Giolitto G, Gravina T, Guerrera B, Gulminetti R, Iacobellis A, Imparato M, Iodice A, Iovinella V, Izzi A, Liberti A, Leo P, Lettieri G, Luppino I, Marrone A, Mazzoni E, Messina V, Monarca R, Narciso V, Nosotti L, Pellicelli AM, Perrella A, Piai G, Picardi A, Pierri P, Pietromatera G, Resta F, Rinaldi L, Romano M, Rossini A, Russello M, Russo G, Sacco R, Sangiovanni V, Schiano A, Sciambra A, Scifo G, Simeone F, Sullo A, Tarquini P, Tundo P, Vallone A. Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. World J Hepatol 2016; 8(22): 949-956
- URL: https://www.wjgnet.com/1948-5182/full/v8/i22/949.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i22.949